華峯測控(688200.SH):六名股東終止詢價轉讓1.34%股份
格隆匯3月15日丨華峯測控(688200.SH)公佈,公司已於2021年3月5日公吿《北京華峯測控技術股份有限公司股東詢價轉讓計劃書》。該次擬詢價轉讓股東為李寅、唐桂琴、陳爰華、王東光、劉惠鵬、趙鐵周(合稱“出讓方”),出讓方擬轉讓股份的總數為81.6917萬股,佔公司總股本的1.34%。
該次詢價轉讓價格下限為340.00元/股,為華峯測控2021年3月4日收盤價392.10元的86.71%,為華峯測控前20個交易日股票交易均價394.00元的86.29%。
因A股市場行情和公司股價出現大幅波動,各方經溝通,同意終止該次詢價轉讓。委託券商同意終止該次發行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.